SELECT MEDICAL HOLDINGS CORP (SEM) Fundamental Analysis & Valuation

NYSE:SEM • US81619Q1058

16.24 USD
+0.04 (+0.25%)
At close: Mar 12, 2026
16.24 USD
0 (0%)
After Hours: 3/12/2026, 8:10:21 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This SEM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SEM. SEM was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of SEM while its profitability can be described as average. SEM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. SEM Profitability Analysis

1.1 Basic Checks

  • In the past year SEM was profitable.
  • In the past year SEM had a positive cash flow from operations.
  • SEM had positive earnings in each of the past 5 years.
  • SEM had a positive operating cash flow in each of the past 5 years.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • SEM has a Return On Assets of 2.44%. This is comparable to the rest of the industry: SEM outperforms 58.42% of its industry peers.
  • SEM has a Return On Equity of 8.38%. This is in the better half of the industry: SEM outperforms 66.34% of its industry peers.
  • SEM has a Return On Invested Capital (5.27%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SEM is below the industry average of 8.98%.
  • The last Return On Invested Capital (5.27%) for SEM is above the 3 year average (4.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROIC 5.27%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With a decent Profit Margin value of 2.62%, SEM is doing good in the industry, outperforming 65.35% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SEM has declined.
  • Looking at the Operating Margin, with a value of 6.17%, SEM is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SEM has declined.
  • With a Gross Margin value of 11.54%, SEM is not doing good in the industry: 71.29% of the companies in the same industry are doing better.
  • SEM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SEM Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SEM is destroying value.
  • The number of shares outstanding for SEM has been reduced compared to 1 year ago.
  • The number of shares outstanding for SEM has been reduced compared to 5 years ago.
  • SEM has a worse debt/assets ratio than last year.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • SEM has an Altman-Z score of 1.62. This is a bad value and indicates that SEM is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.62, SEM is in line with its industry, outperforming 44.55% of the companies in the same industry.
  • SEM has a debt to FCF ratio of 15.74. This is a negative value and a sign of low solvency as SEM would need 15.74 years to pay back of all of its debts.
  • SEM has a Debt to FCF ratio (15.74) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.07 is on the high side and indicates that SEM has dependencies on debt financing.
  • SEM has a worse Debt to Equity ratio (1.07) than 61.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Altman-Z 1.62
ROIC/WACC0.64
WACC8.26%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.04 indicates that SEM should not have too much problems paying its short term obligations.
  • The Current ratio of SEM (1.04) is worse than 67.33% of its industry peers.
  • A Quick Ratio of 1.04 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM has a Quick ratio (1.04) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SEM Growth Analysis

3.1 Past

  • The earnings per share for SEM have decreased strongly by -30.30% in the last year.
  • The Earnings Per Share has been decreasing by -9.36% on average over the past years.
  • The Revenue has been growing slightly by 5.12% in the past year.
  • The Revenue has been decreasing by -0.29% on average over the past years.
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%

3.2 Future

  • Based on estimates for the next years, SEM will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.12% on average per year.
  • SEM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.76% yearly.
EPS Next Y13.52%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
EPS Next 5YN/A
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.76%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. SEM Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.12, the valuation of SEM can be described as correct.
  • SEM's Price/Earnings ratio is rather cheap when compared to the industry. SEM is cheaper than 83.17% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.71, SEM is valued a bit cheaper.
  • SEM is valuated correctly with a Price/Forward Earnings ratio of 12.44.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SEM indicates a rather cheap valuation: SEM is cheaper than 83.17% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.82. SEM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.12
Fwd PE 12.44
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 78.22% of the companies in the same industry are more expensive than SEM, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, SEM is valued a bit cheaper than the industry average as 67.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.18
EV/EBITDA 8.01
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y11.19%
EPS Next 3Y8.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. SEM Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.54%, SEM has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.49, SEM pays a better dividend. On top of this SEM pays more dividend than 89.11% of the companies listed in the same industry.
  • SEM's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

  • SEM has paid a dividend for at least 10 years, which is a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • SEM pays out 21.99% of its income as dividend. This is a sustainable payout ratio.
DP21.99%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SEM Fundamentals: All Metrics, Ratios and Statistics

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (3/12/2026, 8:10:21 PM)

After market: 16.24 0 (0%)

16.24

+0.04 (+0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners82.51%
Inst Owner Change-3.76%
Ins Owners11.15%
Ins Owner Change0.41%
Market Cap2.01B
Revenue(TTM)5.45B
Net Income(TTM)142.92M
Analysts77.78
Price Target17.88 (10.1%)
Short Float %3.39%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP21.99%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.41%
Min EPS beat(2)-31%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)11.24%
Min EPS beat(4)-31%
Max EPS beat(4)49.82%
EPS beat(8)3
Avg EPS beat(8)-11.03%
EPS beat(12)7
Avg EPS beat(12)-1.92%
EPS beat(16)8
Avg EPS beat(16)-6.67%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.43%
Max Revenue beat(2)1.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.37%
Revenue beat(12)8
Avg Revenue beat(12)-0.69%
Revenue beat(16)10
Avg Revenue beat(16)5.67%
PT rev (1m)-3.49%
PT rev (3m)-3.49%
EPS NQ rev (1m)6.9%
EPS NQ rev (3m)6.9%
EPS NY rev (1m)-1.4%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 14.12
Fwd PE 12.44
P/S 0.37
P/FCF 17.18
P/OCF 5.81
P/B 1.18
P/tB N/A
EV/EBITDA 8.01
EPS(TTM)1.15
EY7.08%
EPS(NY)1.31
Fwd EY8.04%
FCF(TTM)0.95
FCFY5.82%
OCF(TTM)2.79
OCFY17.2%
SpS43.97
BVpS13.75
TBVpS-6.1
PEG (NY)1.04
PEG (5Y)N/A
Graham Number18.86
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROCE 6.91%
ROIC 5.27%
ROICexc 5.3%
ROICexgc 10.74%
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
FCFM 2.15%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
ROICexc(3y)4.32%
ROICexc(5y)4.74%
ROICexgc(3y)8.45%
ROICexgc(5y)10.81%
ROCE(3y)5.62%
ROCE(5y)6.16%
ROICexgc growth 3Y36.24%
ROICexgc growth 5Y-11.26%
ROICexc growth 3Y45.51%
ROICexc growth 5Y-3.96%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Debt/EBITDA 3.82
Cap/Depr 163.38%
Cap/Sales 4.2%
Interest Coverage 2.79
Cash Conversion 72.71%
Profit Quality 82.03%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 1.62
F-Score5
WACC8.26%
ROIC/WACC0.64
Cap/Depr(3y)127.38%
Cap/Depr(5y)112.75%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.06%
Profit Quality(3y)122.64%
Profit Quality(5y)96.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
EPS Next Y13.52%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
EPS Next 5YN/A
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.76%
Revenue Next 5YN/A
EBIT growth 1Y25.29%
EBIT growth 3Y32.43%
EBIT growth 5Y-6.78%
EBIT Next Year43.55%
EBIT Next 3Y18.69%
EBIT Next 5YN/A
FCF growth 1Y-60.35%
FCF growth 3Y7.47%
FCF growth 5Y-33.2%
OCF growth 1Y-33.1%
OCF growth 3Y6.75%
OCF growth 5Y-19.55%

SELECT MEDICAL HOLDINGS CORP / SEM FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 5 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 14.12 and the Price/Book (PB) ratio is 1.18.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 3 / 10.